Miaoli, Taiwan

Po-Kuan Chao

This inventor holds 1 USPTO granted patent. Top assignee: National Health Research Institutes. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Po-Kuan Chao. Retrieved from https://idiyas.com/inventor/po-kuan-chao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Po-Kuan Chao

Introduction

Po-Kuan Chao is a distinguished inventor based in Miaoli County, Taiwan, known for his significant contributions to the field of pharmaceutical sciences. With a focus on developing novel compounds, Chao has made strides in addressing opioid receptor-associated conditions, which are crucial in today’s medical landscape.

Latest Patents

Chao holds a patent for "Tetrahydroisoquinolines for use as MOR/NOP dual agonists." This patent discloses compounds of a specific formula, including pharmaceutically acceptable salts. The innovation also includes a method for treating conditions associated with opioid receptors using these compounds, alongside pharmaceutical compositions that comprise them. This significant development highlights Chao's commitment to improving healthcare solutions.

Career Highlights

Po-Kuan Chao is currently affiliated with the National Health Research Institutes, where he continues to contribute to health-related innovations. His dedication to research and development has positioned him as a valuable asset in the field of pharmacology and therapeutics.

Collaborations

Chao collaborates with notable colleagues, including Shau-Hua Ueng and Shiu-Hwa Yeh, reflecting a synergistic approach to research and innovation. These collaborations enable the sharing of ideas and expertise, fostering an environment conducive to groundbreaking discoveries.

Conclusion

In conclusion, Po-Kuan Chao's work illustrates the impact of innovative thinking in addressing challenging medical issues. His patent for Tetrahydroisoquinolines showcases the potential for new therapies aimed at opioid receptor-associated conditions, underscoring the importance of continued research and collaboration in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…